글로벌 요실금 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

최근 몇 년 동안 요실금 시장은 예측 기간 동안 빠르게 성장할 것으로 예상됩니다. "구자라트 주의 젊은 건강한 여성들의 요실금 유병률 - 단면 연구" 연구에 따르면, 건강한 18~25세의 젊은 여성들 사이에서 UI 유병률은 71.85%였고, 2017년 12월부터 2018년 10월까지 11개월 동안의 연구 기간 후 전체 인구 중 50.85%가 스트레스, 9.16%가 충동, 40%가 혼합형 요실금을 보였습니다. 현재 여러 기관에서 여성을 위해 특별히 설계된 기기를 개발하고 있습니다. 이들은 매일 사용할 수 있는 다양한 소형 탐폰과 같은 일회용 기기와 질 탈출증이 있는 여성의 소변 누출을 방지하고 요도를 지지하는 유연한 실리콘 링을 출시하고 있습니다.

Data Bridge Market Research는 요실금 시장이 2021년에 10,863.3백만 달러 규모였으며 2029년까지 19,088.09백만 달러에 도달할 것으로 예상되며 2022년부터 2029년까지의 예측 기간 동안 7.30%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

요실금은 의도치 않게 소변이 새는 것을 말합니다. 남성 요실금은 대부분 손상된 괄약근이나 결함이 있는 방광으로 인해 발생합니다. 방광에서 괄약근은 소변 흐름을 제어하는 ​​원형 근육입니다. 방광에서 체외로 소변을 끌어내는 관인 요도가 손상되면 이 근육은 이를 압착하고 닫는 능력을 잃습니다. 요실금 장치는 소변을 모으고 보관하는 데 도움이 되며 요실금 관리에도 도움이 됩니다. 요실금은 소변이 통제할 수 없이 새어 나오는 상태입니다.

보고 범위 및 시장 세분화

요실금 시장 동향

운전자

• 요실금 유병률 증가

요실금의 유병률 증가는 시장 확장(UI)을 주도하는 주요 요인입니다. 요실금 증상은 요로 감염, 골반저 근육과 요도 괄약근의 약화, 폐경, 임신, 출산, 남성의 근치적 전립선 절제술 후 수술 등 다양한 이유로 발생할 수 있습니다.

• 의료 인프라에 대한 투자 증가

요실금 시장의 성장률에 영향을 미치는 또 다른 중요한 요인은 의료 서비스 지출이 증가하고 있다는 점인데, 이는 관련 인프라를 개선하는 데 도움이 됩니다.

Furthermore, rising initiatives by public and private organizations to spread awareness and increasing number of cases of diabetes, obesity and neurological diseases will expand the urinary incontinence market. Additionally, high disposable income and increasing trend of non-invasive treatment options will result in the expansion of urinary incontinence market. Along with this, rising geriatric population and rising incidences of chronic diseases will enhance the growth rate of the market. Surge in the consumption of sweeteners, caffeine, carbonated drinks, chocolates, sparkling water, muscle relaxants and artificial chili peppers can enhance the risk of urinary incontinence and hence further projected to cushion the market’s growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the urinary incontinence market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the urinary incontinence market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the treatment and devices will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies will challenge the urinary incontinence market. Additionally, the dearth of skilled professionals and complications involved with the procedures will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This urinary incontinence market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinary incontinence market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Urinary incontinence market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Urinary Incontinence Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of urinary incontinence in recent months.

Recent Development

• In May 2020, Rigicon had announced the launch of two new artificial urinary sphincter models named ContiClassic Artificial Urinary Sphincter and ContiReflex Artificial Urinary Sphincter. AUS stands for Artificial Urine Sphincter and is a medical device used to treat urinary incontinence. When non-surgical and behavioural treatment approaches fail, the Artificial Urinary Sphincter is a surgical treatment option.

Global Urinary Incontinence Market Scope

The urinary incontinence market is segmented on the basis of diagnosis, type, treatment type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

• Physical Exam
• Pad Test
• Urodynamic Testing
• Cystoscopy
• Stress Test
• Ultrasound
• Urine Samples

Type

• Stress Incontinence
• Urge Incontinence
• Overflow Incontinence

Treatment Type

• Medication
• Devices
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Urinary Incontinence Market Regional Analysis/Insights

The Urinary incontinence market is analysed and market size insights and trends are provided by country, diagnosis, type, treatment type, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Urinary incontinence market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the urinary incontinence market because of the surging adoption of newer techniques in this region. Additionally, growing presence of major key players and well-established healthcare infrastructure will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to surging number of generic manufacturers and rising government initiatives in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Urinary Incontinence Market Share Analysis

The Urinary incontinence market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinary incontinence market.

Some of the major players operating in the urinary incontinence market are:

• Zydus Cadila (India)
• Torrent Pharmaceuticals Ltd. (India)
• Apotex Inc.
• Eli Lilly and Company (US)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Alembic Pharmaceuticals Limited (India)
• Coloplast Group (Denmark)
• Boston Scientific Corporation (US)
• Alembic Pharmaceuticals Limited (India)
• B. Braun Melsungen AG (Germany)
• BD (US)
• Baxter (US)
• Johnson & Johnson Private Limited (US)
• Medtronic (Ireland)
• AstraZeneca (UK)
• Merck & Co., Inc. (US) 

SKU-53372